Back to Results
First PageMeta Content
Ikaria / Baxter International / The Shaw Group


FOR IMMEDIATE RELEASE IKARIA® NAMES NEW CHAIRMAN -- Daniel Tassé Succeeds David E. Shaw -Clinton, NJ, October 19, 2009 – Ikaria Holdings, Inc. today announced that Board Chairman David E. Shaw is retiring from the bo
Add to Reading List

Document Date: 2011-06-28 11:52:56

Open Document

File Size: 64,30 KB

Share Result on Facebook

City

Seattle / Port Allen / Madison / /

Company

Ikaria Holdings Inc. / Baxter International Inc. / GlaxoSmithKline / BioPharma Solutions / Upjohn / New Mountain Capital / ARCH Venture Partners / Black Point Group / Ikaria Inc. / Current Ikaria / /

Continent

Europe / /

Country

Mexico / Japan / Canada / Australia / /

Currency

USD / /

Event

M&A / Employment Change / FDA Phase / /

Facility

University of Montreal / /

IndustryTerm

manufacturing facility / biotechnology / treatment of hypoxic respiratory failure / treatment of hepatorenal syndrome / acute care products / /

MedicalCondition

liver and kidney injury / acute myocardial infarction / hypoxic respiratory failure / /

Organization

University of Montreal / FDA / /

Person

David E. Shaw -Clinton / Daniel Tassé Succeeds David / Daniel Tassé / David E. Shaw / /

Position

founding CEO / General Manager / Chairman and CEO / Managing Partner / Director / President and CEO / CEO / CHAIRMAN / director / Board Chairman / Chairman of the Board / board member / /

Product

INOmax / INOmax® (nitric oxide) / /

ProvinceOrState

Wisconsin / Louisiana / Washington / /

Region

Latin America / /

Technology

biotechnology / /

URL

www.ikaria.com / /

SocialTag